본문 바로가기

PPAR alpha Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
MOLECULES26(11) · 2021
피인용
Web of Science 16Scopus 17
FWCI (Scopus)
0.99
JCR IF
JCR 2020 4.412
ISSN
1420-3049

저자

  1. 김민조제1저자Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
  2. 김대현Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
  3. 방은진Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
  4. 노상균Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
  5. Chun, PusoonCollege of Pharmacy, Inje University, Gyeongsangnam‐do, Gimhae, 50834, Korea;
  6. Yokozawa, TakakoGraduate School Science and Engineering for Research, University of Toyama, Toyama, 930‐8555, Japan
  7. 문형룡교신저자Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;
  8. 정해영교신저자Department of Pharmacy, College of Pharmacy, Pusan National University, Geumjeong‐gu, Busan, 46241, Korea;

초록

PPAR alpha is a ligand-dependent transcription factor and its activation is known to play an important role in cell defense through anti-inflammatory and antioxidant effects. MHY3200 (2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2,2-difluoroacetic acid), a novel benzothiazole-derived peroxisome proliferator-activated receptor alpha (PPAR alpha) agonist, is a synthesized PPAR alpha activator. This study examined the beneficial effects of MHY3200 on age-associated alterations in reactive oxygen species (ROS)/Akt/forkhead box (FoxO) 1 signaling in rat kidneys. Young (7-month-old) and old (22-month-old) rats were treated with MHY3200 (1 mg/kg body weight/day or 3 mg/kg body weight/day) for two weeks. MHY3200 treatment led to a notable decrease in triglyceride and insulin levels in serum from old rats. The elevated kidney ROS level, serum insulin level, and Akt phosphorylation in old rats were reduced following MHY3200 treatment; moreover, FoxO1 phosphorylation increased. MHY3200 treatment led to the increased level of FoxO1 and its target gene, MnSOD. MHY3200 suppressed cyclooxygenase-2 expression by activating PPAR alpha and inhibiting the activation of nuclear factor-kappa B (NF-kappa B) in the kidneys of old rats. Our results suggest that MHY3200 ameliorates age-associated renal inflammation by regulating NF-kappa B and FoxO1 via ROS/Akt signaling.

키워드

agingMHY3200ROSAktNF-kappa BinflammationTRANSCRIPTION FACTORSOXIDATIVE STRESSPEROXISOME PROLIFERATORACTIVATED RECEPTORSMODULATIONAGEFOXORESTRICTIONHYPOTHESISMETABOLISM

식별자

Scopus EID
2-s2.0-85107424702
WoS UID
000660362900001